Human induced pluripotent stem cell (iPSC)-based models are a valuable resource for studying disease mechanisms in vitro at the cellular level[1], screening potential new therapeutics[2], and investigating the propensity and mechanism for the development of toxic side effects caused by a drug treatment[3]. Such iPSC-based models enable research to be performed under defined experimental conditions and in a reproducible manner. [Read more…]
2024 HEALinc Future Health Summit to Convene Experts in Longevity and Regenerative Health
Over April 28-30th, 2024, on Paradise Island in The Bahamas, the 2024 HEALinc Future Health Summit will be convening experts from across the fields of longevity, cellular medicine, and regenerative health. The event will bring together the world’s top scientists, investors, healthcare providers, longevity tech companies, and stem cell companies. By attending, you will be positioned to learn about cutting-edge future health medicines and technologies that can support peak performance at any age. [Read more…]
Who Is CryoHoldco? Latin America’s Largest Cord Blood Bank
CryoHoldco is a stem cell bank holding company that is the market leader in Latin America and one of the top 10 largest cord blood banks in the world. CryoHoldco is now seven times larger than any other stem cell bank in Latin America with over 275,000 stem cell units in storage.
Historical Data on the Global Cord Blood and Tissue Banking Services Market
The Global Cord Blood and Tissue Banking Services Market is composed of revenue produced by companies that are engaged with the collection, processing, storage, and release of umbilical cord blood and tissue products. The global cord blood industry came into existence in the early 1990’s with the formation of a handful of cord blood banks within the United States. Shortly thereafter, these companies began being established in other regions as well. [Read more…]
LifeCell International, India’s Largest Cord Blood Bank
LifeCell is India’s largest cord blood bank, offering stem cell banking services and diagnostic testing. Established in 2004, its BabyCord program is one of the largest cord blood banking programs in the region, with 50,000+ parents preserving newborn stem cells each year and 375,000 units cryopreserved.
I had the privilege of interviewing Mr. Mayur Abhaya Srisrimal, Chief Executive Officer and Managing Director of LifeCell. Mr. Abhaya has led LifeCell since 2008 and been instrumental in expanding its stem cell storage services across India with its BabyCord program. Under his leadership, LifeCell also raised growth capital from Helion Ventures and extended its preventive diagnostic services by launching BabyShield, a program targeted at reducing the infant mortality ratio. [Read more…]
- « Previous Page
- 1
- …
- 7
- 8
- 9
- 10
- 11
- …
- 314
- Next Page »